J 2018

Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes

AĆIMOVIĆ, Ivana; Marwan M. REFAAT; Adrien MOREAU; Anton SALYKIN; Steve REIKEN et. al.

Basic information

Original name

Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes

Authors

AĆIMOVIĆ, Ivana (688 Serbia, belonging to the institution); Marwan M. REFAAT (422 Lebanon); Adrien MOREAU (250 France); Anton SALYKIN (643 Russian Federation, belonging to the institution); Steve REIKEN (840 United States of America); Yvonne SLEIMAN (250 France); Monia SOUIDI (250 France); Jan PŘIBYL (203 Czech Republic, belonging to the institution); Andrey V. KAJAVA (643 Russian Federation); Sylvian RICHARD (250 France); Jonathan T. LU (840 United States of America); Philippe CHEVALIER (250 France); Petr SKLÁDAL (203 Czech Republic, belonging to the institution); Petr DVOŘÁK (203 Czech Republic, belonging to the institution); Vladimír ROTREKL (203 Czech Republic, belonging to the institution); Andrew R. MARKS (840 United States of America); Melvin M. SCHEINMAN (840 United States of America); Alain LACAMPAGNE (250 France, guarantor) and Albano C. MELI (250 France)

Edition

JOURNAL OF CLINICAL MEDICINE, BASEL, MDPI, 2018, 2077-0383

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

Switzerland

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 5.688

RIV identification code

RIV/00216224:14110/18:00101651

Organization unit

Faculty of Medicine

UT WoS

000451311900046

EID Scopus

2-s2.0-85082178921

Keywords in English

ryanodine receptor; CPVT; hiPSC-derived cardiomyocytes; calcium; beta-adrenergic receptor blockade; flecainide; post-translational modifications

Tags

International impact, Reviewed
Changed: 7/3/2019 16:32, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Background: Sarcoplasmic reticulum Ca2+ leak and post-translational modifications under stress have been implicated in catecholaminergic polymorphic ventricular tachycardia (CPVT), a highly lethal inherited arrhythmogenic disorder. Human induced pluripotent stem cells (hiPSCs) offer a unique opportunity for disease modeling. Objective: The aims were to obtain functional hiPSC-derived cardiomyocytes from a CPVT patient harboring a novel ryanodine receptor (RyR2) mutation and model the syndrome, drug responses and investigate the molecular mechanisms associated to the CPVT syndrome. Methods: Patient-specific cardiomyocytes were generated from a young athletic female diagnosed with CPVT. The contractile, intracellular Ca2+ handling and electrophysiological properties as well as the RyR2 macromolecular remodeling were studied. Results: Exercise stress electrocardiography revealed polymorphic ventricular tachycardia when treated with metoprolol and marked improvement with flecainide alone. We found abnormal stress-induced contractile and electrophysiological properties associated with sarcoplasmic reticulum Ca2+ leak in CPVT hiPSC-derived cardiomyocytes. We found inadequate response to metoprolol and a potent response of flecainide. Stabilizing RyR2 with a Rycal compound prevents those abnormalities specifically in CPVT hiPSC-derived cardiomyocytes. The RyR2-D3638A mutation is located in the conformational change inducing-central core domain and leads to RyR2 macromolecular remodeling including depletion of PP2A and Calstabin2. Conclusion: We identified a novel RyR2-D3638A mutation causing 3D conformational defects and aberrant biophysical properties associated to RyR2 macromolecular complex post-translational remodeling. The molecular remodeling is for the first time revealed using patient-specific hiPSC-derived cardiomyocytes which may explain the CPVT proband's resistance. Our study promotes hiPSC-derived cardiomyocytes as a suitable model for disease modeling, testing new therapeutic compounds, personalized medicine and deciphering underlying molecular mechanisms.

Links

GBP302/12/G157, research and development project
Name: Dynamika a organizace chromosomů během buněčného cyklu a při diferenciaci v normě a patologii
Investor: Czech Science Foundation
LM2015043, research and development project
Name: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
2SGA2744, interní kód MU
Name: CARDIOSTEM (Acronym: CARDIOSTEM)
Investor: South-Moravian Region, Incoming grants